Demontis Gian Carlo, Pezzini Francesco, Margari Elisa, Bianchi Marzia, Longoni Biancamaria, Doccini Stefano, Lalowski Maciej Maurycy, Santorelli Filippo Maria, Simonati Alessandro
Department of Pharmacy, University of Pisa, Pisa, Italy.
Neurology (Child Neurology and Neuropathology), Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
Front Cell Neurosci. 2020 Dec 16;14:569598. doi: 10.3389/fncel.2020.569598. eCollection 2020.
CLN1 disease (OMIM #256730) is an inherited neurological disorder of early childhood with epileptic seizures and premature death. It is associated with mutations in coding for Palmitoyl-Protein Thioesterase 1 (PPT1), a lysosomal enzyme which affects the recycling and degradation of lipid-modified (S-acylated) proteins by removing palmitate residues. Transcriptomic evidence from a neuronal-like cellular model derived from differentiated SH-SY5Y cells disclosed the potential negative roles of overexpression, affecting the elongation of neuronal processes and the expression of selected proteins of the synaptic region. Bioinformatic inquiries of transcriptomic data pinpointed a dysregulated expression of several genes coding for proteins related to voltage-gated ion channels, including subunits of calcium and potassium channels (VGCC and VGKC). In SH-SY5Y cells overexpressing (SH- cells), the resting potential and the membrane conductance in the range of voltages close to the resting potential were not affected. However, patch-clamp recordings indicated a reduction of Ba currents through VGCC of SH- cells; Ca imaging revealed reduced Ca influx in the same cellular setting. The results of the biochemical and morphological investigations of CACNA2D2/αδ-2, an accessory subunit of VGCC, were in accordance with the downregulation of the corresponding gene and consistent with the hypothesis that a lower number of functional channels may reach the plasma membrane. The combined use of 4-AP and NS-1643, two drugs with opposing effects on K11 and K12 subfamilies of VGKC coded by the gene family, provides evidence for reduced functional K12 channels in SH- cells, consistent with transcriptomic data indicating the downregulation of . The lack of compelling evidence supporting the palmitoylation of many ion channels subunits investigated in this study stimulates inquiries about the role of PPT1 in the trafficking of channels to the plasma membrane. Altogether, these results indicate a reduction of functional voltage-gated ion channels in response to /PPT1 overexpression in differentiated SH-SY5Y cells and provide new insights into the altered neuronal excitability which may underlie the severe epileptic phenotype of CLN1 disease. It remains to be shown if remodeling of such functional channels on plasma membrane can occur as a downstream effect of CLN1 disease.
CLN1病(OMIM #256730)是一种儿童期遗传性神经疾病,伴有癫痫发作和过早死亡。它与编码棕榈酰蛋白硫酯酶1(PPT1)的基因突变有关,PPT1是一种溶酶体酶,通过去除棕榈酸残基来影响脂质修饰(S-酰化)蛋白的再循环和降解。来自分化的SH-SY5Y细胞的神经元样细胞模型的转录组学证据揭示了PPT1过表达的潜在负面作用,影响神经元突起的伸长和突触区域所选蛋白质的表达。对转录组数据的生物信息学查询指出,几个编码与电压门控离子通道相关蛋白质的基因表达失调,包括钙通道和钾通道(VGCC和VGKC)的亚基。在过表达PPT1的SH-SY5Y细胞(SH-PPT1细胞)中,静息电位和接近静息电位的电压范围内的膜电导不受影响。然而,膜片钳记录表明SH-PPT1细胞通过VGCC的Ba电流减少;钙成像显示在相同细胞环境中钙内流减少。VGCC的辅助亚基CACNA2D2/αδ-2的生化和形态学研究结果与相应基因的下调一致,并与功能通道数量较少可能到达质膜的假设一致。联合使用对由KCN基因家族编码的VGKC的K11和K12亚家族有相反作用的两种药物4-AP和NS-1643,为SH-PPT1细胞中功能性K12通道减少提供了证据,这与转录组数据表明KCN下调一致。本研究中对许多离子通道亚基缺乏支持棕榈酰化的有力证据,引发了对PPT1在通道向质膜运输中的作用的质疑。总之,这些结果表明,在分化的SH-SY5Y细胞中,响应PPT1过表达,功能性电压门控离子通道减少,并为可能是CLN1病严重癫痫表型基础的神经元兴奋性改变提供了新见解。尚有待证明质膜上这种功能性通道的重塑是否会作为CLN1病的下游效应而发生。